AttendMe Owl Logo
AttendMe
Evidence Evolution
Trauma SurgeryTrauma Surgery

How This Evidence Evolved

Non-Operative Management of Solid Organ Injury

Observation replaces the knife

1980-202431.4

Timeline

King 1954
1952
Upadhyaya 1968
1968
Pachter 1998
1996
Peitzman 2000
2000
Haan 2005
2004
Demetriades 2006
2006
EAST
2012
WSES
2017
Trial
Guideline
Approval
Meta-analysis
Signal

Early observations and pilot data that first suggested a new direction

For most of the 20th century, any solid organ injury diagnosed at laparotomy or suspected clinically mandated surgical exploration. Splenic injuries were treated with splenectomy, liver lacerations with packing or repair, and kidney injuries with nephrectomy. The recognition of overwhelming post-splenectomy infection (OPSI) in the 1970s and 1980s created pressure to preserve the spleen, initially through splenic repair (splenorrhaphy) rather than removal. Simultaneously, the advent of CT scanning in trauma allowed accurate grading of solid organ injuries without surgery, revealing that many injuries were self-limited and did not require operative intervention. Pediatric surgeons led the way, demonstrating that children with splenic and hepatic injuries could be safely observed, setting the stage for adult NOM.
Proof

Landmark RCTs and pivotal trials that established the evidence base

Large institutional series from level I trauma centers in the 1990s and 2000s established that NOM of blunt splenic and hepatic injuries was safe in hemodynamically stable patients, regardless of injury grade. Peitzman and colleagues at Pittsburgh demonstrated NOM success rates exceeding 90% for low-grade splenic injuries and 60-70% for high-grade injuries. The National Trauma Data Bank analyses confirmed that NOM rates for splenic injury rose from 40% in the 1990s to over 70% by the mid-2000s, with concurrent decreases in overall mortality. For liver injuries, Pachter and Feliciano published definitive series showing that NOM succeeded in over 80% of blunt hepatic injuries, including high-grade lacerations, provided the patient remained hemodynamically stable. These large observational datasets, rather than RCTs, drove the paradigm shift because randomizing patients to unnecessary laparotomy became ethically untenable.
Extension

Follow-up studies, subgroup analyses, and real-world validation

The critical extension that enabled NOM of high-grade injuries was angiography with embolization. Haan and colleagues demonstrated that CT evidence of active contrast extravasation (blush) could be treated with angioembolization rather than surgery, converting many previously operative injuries into successful NOM cases. This was particularly transformative for high-grade splenic injuries (AAST grades IV-V), where angioembolization increased NOM success rates from approximately 50% to over 85%. The concept expanded to renal injuries, where NOM with selective angioembolization is now standard for even grade IV-V blunt kidney injuries in stable patients. More recently, NOM principles have been cautiously extended to selected penetrating abdominal injuries in hemodynamically stable patients without peritonitis, guided by CT findings—a concept that would have been heretical a generation ago.
Guidelines

Integration into clinical practice guidelines and recommendations

The AAST (American Association for the Surgery of Trauma) and WSES (World Society of Emergency Surgery) guidelines now recommend NOM as the treatment of choice for all hemodynamically stable patients with blunt solid organ injuries, regardless of injury grade. The WSES 2017 splenic injury guidelines and 2020 liver and kidney guidelines provide detailed algorithms incorporating CT grading, contrast blush, and angioembolization. Key criteria for NOM include hemodynamic stability (or rapid response to resuscitation), absence of peritonitis, and availability of ICU monitoring and interventional radiology. The EAST guidelines recommend against routine follow-up CT in patients who are clinically improving, reducing unnecessary radiation exposure.
WSES Classification and Guidelines for Splenic Trauma

NOM is the treatment of choice for hemodynamically stable blunt splenic injuries of all AAST grades; angioembolization recommended for grade III+ with contrast blush

EAST Practice Management Guidelines for Non-Operative Management of Blunt Hepatic Injury

NOM is recommended for all hemodynamically stable patients with blunt hepatic injury regardless of grade; routine follow-up imaging not required if clinically improving

Now

Current standard of care and ongoing research directions

NOM is now the standard of care for over 80% of blunt solid organ injuries in adults, representing one of the most dramatic practice changes in trauma surgery. Current research focuses on refining failure prediction using CT-based scoring systems and biomarkers, optimizing angioembolization techniques (proximal vs distal splenic embolization), and determining which patients require ICU-level monitoring versus step-down observation. The extension of NOM to penetrating injuries remains controversial but is gaining acceptance at high-volume centers. Long-term outcomes research has largely allayed concerns about delayed rupture and missed injuries, though the rare catastrophic NOM failure remains a clinical and medicolegal challenge. The integration of hybrid operating rooms (combining surgical and interventional radiology capabilities) represents the next evolution, allowing seamless transition from NOM to endovascular or open intervention when needed.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

What is the NOM failure rate for high-grade splenic injuries?+
Without angioembolization, NOM failure rates for AAST grade IV-V splenic injuries range from 30-50%. With adjunctive angioembolization for contrast blush on CT, failure rates drop to 10-15%. Most failures occur within the first 72 hours. Delayed splenic rupture beyond 7 days is rare (<1%) but can be catastrophic, underscoring the need for appropriate patient selection, monitoring, and patient education about warning signs after discharge.
What are the absolute contraindications to NOM of solid organ injuries?+
Absolute contraindications include hemodynamic instability unresponsive to resuscitation, peritonitis on clinical examination, and evisceration. Relative contraindications include coagulopathy (anticoagulant use, liver disease), unreliable clinical exam (TBI, intoxication, spinal cord injury), and lack of institutional resources (no ICU monitoring, no interventional radiology availability). Patient age alone is not a contraindication, though elderly patients have higher NOM failure rates.
When is angioembolization indicated as an adjunct to NOM?+
Angioembolization is indicated when CT demonstrates active contrast extravasation (blush), pseudoaneurysm, or arteriovenous fistula within the injured organ. For splenic injuries, some protocols recommend prophylactic embolization for all grade IV-V injuries even without blush, though this remains debated. Embolization should be performed within 1-2 hours of CT diagnosis for active extravasation. The choice between proximal and distal splenic artery embolization depends on the injury pattern and institutional preference.
Can penetrating abdominal injuries be managed non-operatively?+
Selected penetrating injuries can be managed non-operatively in hemodynamically stable patients without peritonitis, provided triple-contrast CT demonstrates an isolated solid organ injury without hollow viscus involvement. This approach is best established for right thoracoabdominal stab wounds with isolated liver injury. It requires serial clinical examination by experienced trauma surgeons and is generally reserved for high-volume trauma centers. NOM of gunshot wounds to the abdomen remains controversial and is practiced only at select centers.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Last reviewed: 3 April 2026